S M Ayub-Ferreira, M S Avila, F S Feitosa, G E C Souza, S Mangini, F G Marcondes-Braga, V S Issa, F Bacal, P R Chizzola, F D D Cruz, E A Bocchi
BACKGROUND: Renal failure is the most important comorbidity in patients with heart transplantation, it is associated with increased mortality. The major cause of renal dysfunction is the toxic effects of calcineurin inhibitors (CNI). Sirolimus, a proliferation signal inhibitor, is an imunossupressant recently introduced in cardiac transplantation. Its nonnephrotoxic properties make it an attractive immunosuppressive agent for patients with renal dysfunction. In this study, we evaluated the improvement in renal function after switching the CNI to sirolimus among patients with new-onset kidney dysfunction after heart transplantation...
March 2010: Transplantation Proceedings